Reckamp KL, Redman MW, Dragnev KH, Minichiello K, et al. Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MAP S1800A. J Clin Oncol 2022 Jun 3:JCO2200912. doi: 10.1200/JCO.22.00912.
PMID: 35658002